Patents by Inventor Jean-Charles Dagorn

Jean-Charles Dagorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040198679
    Abstract: The invention relates to the use of inhibitors of expression or activity of p8/com1 for treating tumours.
    Type: Application
    Filed: April 21, 2004
    Publication date: October 7, 2004
    Inventors: Sophie Vasseur, Juan Iovanna, Jean-Charles Dagorn
  • Patent number: 5959086
    Abstract: The invention relates to the family of the protein (PAP) associated with acute pancreatitis in man and in the rat. It also relates to the nucleotide fragments coding for the above proteins. Also included in the framework of the invention are antibodies which recognize the PAP and which are capable of being used for the purpose of diagnosing pancreatitis. The invention also relates to the production of the PAP, in particular by genetic engineering.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: September 28, 1999
    Assignee: Institut National de la Santa et de la Recherche Medicale
    Inventors: Juan-Lucio Iovanna, Volker Keim, Jean-Charles Dagorn
  • Patent number: 5834214
    Abstract: The invention relates to in vitro detection of human pancreatitis-associated protein (hPAP) for the purpose of screening for cystic fibrosis. hPAP is quantitated in a biological sample, preferably blood, and a high value is indicative of pancreatic dysfunction. Immunoassays as rapid, reliable methods for hPAP quantitation are provided as are antibodies for use in the assays and hybridomas for production of monoclonal antibodies preferred for use in the assays.
    Type: Grant
    Filed: August 30, 1995
    Date of Patent: November 10, 1998
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Juan-Lucio Iovanna, Jean-Charles Dagorn, Volker Keim, Jacques Sarles
  • Patent number: 5436169
    Abstract: The invention relates to the family of the protein (PAP) associated with acute pancreatitis in man and in the rat. It also relates to the nucleotide fragments coding for the above proteins.Also included in the framework of the invention are antibodies which recognize the PAP and which are capable of being used for the purpose of diagnosing pancreatitis.The invention also relates to the production of the PAP, in particular by genetic engineering.
    Type: Grant
    Filed: December 19, 1991
    Date of Patent: July 25, 1995
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Juan-Lucio Iovanna, Keim Volker, Jean-Charles Dagorn